scroll to top
0

EBSCO Auth Banner

Let's find your institution. Click here.

Advanced Search Results For "COVID-19 Vaccines"

1 - 10 of 99,012 results for
 "COVID-19 Vaccines"
Results per page:

Real-world comparative effectiveness of mRNA-1273 and BNT162b2 vaccines among immunocompromised adults identified in administrative claims data in the United States.

Publication Type: Academic Journal

Source(s): Vaccine [Vaccine] 2022 Nov 08; Vol. 40 (47), pp. 6730-6739. Date of Electronic Publication: 2022 Sep 24.

Abstract: Introduction: Head-to-head studies comparing COVID-19 mRNA vaccine effectiveness in immunocompromised individuals, who are vulnerable to severe disease are lacking, as large sample sizes are required to make meaningful inferences.Methods: This observat...

View details

Characteristics Associated With a Previous COVID-19 Diagnosis, Vaccine Uptake, and Intention to Be Vaccinated Among Essential Workers in the US Household Pulse Survey.

Publication Type: Academic Journal

Source(s): American journal of public health [Am J Public Health] 2022 Nov; Vol. 112 (11), pp. 1599-1610.

Abstract: Objectives. To explore previous COVID-19 diagnosis and COVID-19 vaccination status among US essential worker groups. Methods. We analyzed the US Census Household Pulse Survey (May 26-July 5, 2021), a nationally representative sample of adults aged 18 y...

View details

Risk of Myocarditis After Sequential Doses of COVID-19 Vaccine and SARS-CoV-2 Infection by Age and Sex.

Publication Type: Academic Journal

Source(s): Circulation [Circulation] 2022 Sep 06; Vol. 146 (10), pp. 743-754. Date of Electronic Publication: 2022 Aug 22.

Abstract: Background: Myocarditis is more common after severe acute respiratory syndrome coronavirus 2 infection than after COVID-19 vaccination, but the risks in younger people and after sequential vaccine doses are less certain.Methods: A self-controlled case ...

View details

Age and product dependent vaccine effectiveness against SARS-CoV-2 infection and hospitalisation among adults in Norway: a national cohort study, July-November 2021.

Publication Type: Academic Journal

Source(s): BMC medicine [BMC Med] 2022 Sep 02; Vol. 20 (1), pp. 278. Date of Electronic Publication: 2022 Sep 02.

Abstract: Background: COVID-19 vaccines have been crucial in the pandemic response and understanding changes in vaccines effectiveness is essential to guide vaccine policies. Although the Delta variant is no longer dominant, understanding vaccine effectiveness p...

View details

[Effectiveness of BNT162b2 vaccine to preventing COVID-19 in healthcare personnel].

Publication Type: Academic Journal

Source(s): Gaceta sanitaria [Gac Sanit] 2022 Sep-Oct; Vol. 36 (5), pp. 484-487. Date of Electronic Publication: 2021 Nov 26.

Abstract: Objective: To assess the effectiveness of the vaccine against SARS-CoV-2 (BNT162b2) in healthcare personnel of a health department.Method: Test-negative case̶control study. Healthcare personnel with suspected COVID-19 and healthcare personnel close con...

View details

Comparison of test-negative and syndrome-negative controls in SARS-CoV-2 vaccine effectiveness evaluations for preventing COVID-19 hospitalizations in the United States.

Publication Type: Academic Journal

Source(s): Vaccine [Vaccine] 2022 Nov 15; Vol. 40 (48), pp. 6979-6986. Date of Electronic Publication: 2022 Oct 24.

Abstract: Background: Test-negative design (TND) studies have produced validated estimates of vaccine effectiveness (VE) for influenza vaccine studies. However, syndrome-negative controls have been proposed for differentiating bias and true estimates in VE evalu...

View details

The Waning of BNT162b2 Vaccine Effectiveness for SARS-CoV-2 Infection Prevention over Time: A Test-Negative Study in Health Care Professionals of a Health Department from January 2021 to December 2021.

Publication Type: Academic Journal

Source(s): International journal of environmental research and public health [Int J Environ Res Public Health] 2022 Oct 25; Vol. 19 (21). Date of Electronic Publication: 2022 Oct 25.

Abstract: The duration of protection of vaccines against SARS-CoV-2 infection has been evaluated in previous studies, but uncertainty remains about the persistence of effectiveness over time and the ideal timing for booster doses. Therefore, the aim of this stud...

View details

COVID-19 vaccine hesitancy among Israeli adults before and after vaccines' availability: A cross-sectional national survey.

Publication Type: Academic Journal

Source(s): Vaccine [Vaccine] 2022 Oct 12; Vol. 40 (43), pp. 6271-6276. Date of Electronic Publication: 2022 Sep 14.

Abstract: Vaccine hesitancy (VH) is a major health threat to the efforts to tackle COVID-19 morbidity and mortality. This study's objectives were to assess COVID-19VH before and after vaccines' availability and to analyze the associations between COVID-19VH and ...

View details

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults.

Publication Type: Academic Journal

Source(s): Vaccine [Vaccine] 2022 Sep 22; Vol. 40 (40), pp. 5798-5805. Date of Electronic Publication: 2022 Aug 31.

Abstract: Introduction: In 2020, prior to COVID-19 vaccine rollout, the Brighton Collaboration created a priority list, endorsed by the World Health Organization, of potential adverse events relevant to COVID-19 vaccines. We adapted the Brighton Collaboration li...

View details

A dual-antigen self-amplifying RNA SARS-CoV-2 vaccine induces potent humoral and cellular immune responses and protects against SARS-CoV-2 variants through T cell-mediated immunity.

Publication Type: Academic Journal

Source(s): Molecular therapy : the journal of the American Society of Gene Therapy [Mol Ther] 2022 Sep 07; Vol. 30 (9), pp. 2968-2983. Date of Electronic Publication: 2022 Apr 20.

Abstract: Self-amplifying RNA vaccines may induce equivalent or more potent immune responses at lower doses compared to non-replicating mRNA vaccines via amplified antigen expression. In this paper, we demonstrate that 1 μg of an LNP-formulated dual-antigen self...

View details
sponsored